ArticleFrontiers in public health2025
Mental symptoms in post-COVID syndrome and post-COVID-19 vaccination syndrome: results of a representative population survey.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mental symptoms such as fatigue, concentration difficulties, and sleep disorders are frequently reported in both Post-COVID Syndrome (PCS) and Post-COVID-19 Vaccination Syndrome (PCVS). Although symptom profiles may overlap, comparative epidemiological data from the general population are limited. Methods: We conducted a representative online survey of 4,632 adults in Germany and investigated mental symptoms associated with PCS and PCVS, including fatigue, cognitive problems, sleep disturbances, impaired performance and depressed mood. Socio-demographic factors, vaccination status, vaccine type and number of vaccinations were analysed. Results: The prevalence of self-reported mental symptoms of PCS was 12.1% among respondents, with women and younger individuals more commonly affected. The prevalence of self-reported PCVS was 12.6% among vaccinated individuals, with no significant gender differences, but fewer cognitive symptoms in older adults. Respondents with only one vaccination reported the highest rate of PCVS symptoms (20.8%), which decreased to 8.9% for those with four or more vaccinations. Differences between vaccine types were small overall, but non-mRNA vaccines were associated with a slightly higher rate of sleep and concentration problems. Conclusion: Mental symptoms are relatively common after both SARS-CoV-2 infection and vaccination and show overlap, especially fatigue. These findings highlight how difficult it is to distinguish PCS from PCVS and emphasize the need to consider alternative explanations, such as undiagnosed depressive disorders, in clinical assessments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.